Department of Internal Medicine II, University Hospital Giessen and Marburg, Justus-Liebig-University Giessen, Giessen, Germany.
Department of Internal Medicine, Institute for Lung Health (ILH), Universities of Giessen and Marburg Lung Center (UGMLC), Cardio-Pulmonary Institute (CPI), Member of the German Center for Lung Research (DZL), Giessen, Germany.
Clin Transplant. 2024 Sep;38(9):e15457. doi: 10.1111/ctr.15457.
Post-lung transplantation (LTx) fluid accumulation can lead to dilution of serum creatinine (SCr). We hypothesized that fluid accumulation might impact the diagnosis, staging, and outcome of posttransplant acute kidney injury (AKI).
In this retrospective study, we analyzed data from 131 adult LTx patients at a single German lung center between 2005 and 2018. We assessed the occurrence of AKI within 7 days posttransplant, both before and after SCr-adjustment for fluid balance (FB), and investigated its impact on all-cause mortality. Transient and persistent AKIs were defined as return to baseline kidney function or continuation of AKI beyond 72 h of onset, respectively.
AKI was diagnosed in 58.8% of patients according to crude SCr values. When considering FB-adjusted SCr values, AKI severity was underestimated in 20.6% of patients, that is, AKI was detected in an additional 6.9% of patients and led to AKI upstaging in 23.4% of cases. Patients initially underestimated but detected with AKI only after FB adjustment had higher mortality compared to those who did not meet AKI criteria (hazard ratio [HR] 2.98; 95% confidence interval [CI] 1.06, 8.36; p = 0.038). Persistent AKI was associated with higher mortality than transient AKI, regardless of using crude or adjusted SCr values (p < 0.05). Persistent AKI emerged as an independent risk factor for mortality (HR 2.35; 95% CI 1.29, 4.30; p = 0.005).
Adjusting for FB and evaluating renal recovery patterns post-AKI may enhance the sensitivity of AKI detection. This approach could help identify patients with poor prognosis and potentially improve outcomes in lung transplant recipients.
ClinicalTrials.gov identifier: NCT03039959, NCT03046277.
肺移植(LTx)后液体蓄积可导致血清肌酐(SCr)稀释。我们假设液体蓄积可能会影响移植后急性肾损伤(AKI)的诊断、分期和结果。
在这项回顾性研究中,我们分析了 2005 年至 2018 年间德国一家肺中心的 131 名成年 LTx 患者的数据。我们评估了移植后 7 天内 AKI 的发生情况,包括未调整和调整了液体平衡(FB)后的 SCr 值,并研究了其对全因死亡率的影响。分别将短暂性和持续性 AKI 定义为恢复至基线肾功能或 AKI 持续超过 72 小时。
根据原始 SCr 值,58.8%的患者诊断为 AKI。当考虑 FB 调整后的 SCr 值时,20.6%的患者 AKI 严重程度被低估,即另外有 6.9%的患者被检测出 AKI,并导致 23.4%的病例 AKI 升级。与未达到 AKI 标准的患者相比,最初被低估但仅在 FB 调整后才被检测出 AKI 的患者死亡率更高(风险比[HR] 2.98;95%置信区间[CI] 1.06,8.36;p = 0.038)。无论使用原始还是调整后的 SCr 值,持续性 AKI 与更高的死亡率相关,而非短暂性 AKI(p < 0.05)。持续性 AKI 是死亡率的独立危险因素(HR 2.35;95%CI 1.29,4.30;p = 0.005)。
调整 FB 并评估 AKI 后肾脏恢复模式可能会提高 AKI 的检测灵敏度。这种方法可以帮助识别预后不良的患者,并有可能改善肺移植受者的预后。
ClinicalTrials.gov 标识符:NCT03039959,NCT03046277。